Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probiotic Pur
- Development stage
- Unknown
- Lead developer
- Van Yuzuncu Yil University
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Probiotic Pur is a multi-strain probiotic dietary supplement that was evaluated in a Phase 3 clinical trial led by Yuzuncu Yil University for the treatment of atopic dermatitis in children. The formulation consists of four specific bacterial strains: *Bifidobacterium bifidum*, *Lactobacillus acidophilus*, *Lactobacillus casei*, and *Lactobacillus salivarius*. The supplement is intended to modulate the gut-skin axis and immune response to alleviate symptoms of medium-to-heavy atopic dermatitis. Clinical study results indicated that the probiotic was effective in reducing SCORAD (Scoring Atopic Dermatitis) index levels in pediatric patients, although it did not significantly impact other immunological markers such as serum cytokines (IL-2, IL-4, IL-5, IL-6, IL-10, TNF-α, IFN-γ), eosinophil cationic protein (ECP), or total and specific IgE levels.
- Brand names
- Probiotic Pur
- Other names
- probiotic ® purMulti-strain probiotic supplement (Yuzuncu Yil University)
Beyond the preview
Go deeper on Probiotic Pur.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probiotic Pur.